このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Zhongzhu Healthcare HoldingLtd マネジメント

マネジメント基準チェック /14

現在、CEO に関する十分な情報がありません。

主要情報

Bo Anna Wang

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	no data
CEOの所有権	n/a
経営陣の平均在職期間	データなし
取締役会の平均在任期間	5.3yrs

経営陣の近況

Recent updates

Zhongzhu Healthcare Holding Co.,Ltd (SHSE:600568) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

May 13

CEO（最高経営責任者

Bo Anna Wang (61 yo)

no data

在職期間

Ms. Bo Anna Wang serves as President of Zhongzhu Healthcare Holding Co.,Ltd.

取締役

名称	ポジション	在職期間	報酬	所有権
Bao Long Qiao	VP & Director	5.3yrs	CN¥470.00k	データなし
Jige Ye	Chairman	5.3yrs	CN¥1.43m	0.17% CN¥ 4.1m
Dong Mei Huang	Member of the Supervisory Board	no data	データなし	データなし
Jian Li	Member of the Supervisory Board	no data	データなし	データなし
Yi Bin Zeng	Independent Director	5.3yrs	データなし	データなし
Zhen Xin Yang	Independent Director	5.3yrs	データなし	データなし
Qin Xu	Employee Supervisor	3.8yrs	データなし	データなし
Lang Chen	Independent Director	no data	データなし	データなし

5.3yrs

平均在職期間

52.5yo

平均年齢

経験豊富なボード: 600568の取締役会は経験豊富であると考えられます ( 5.2年の平均在任期間)。

Zhongzhu Healthcare HoldingLtd マネジメント

マネジメント 基準チェック /14

主要情報

経営陣の近況

Zhongzhu Healthcare Holding Co.,Ltd, Annual General Meeting, May 08, 2024

Insufficient new directors

Recent updates

Zhongzhu Healthcare Holding Co.,Ltd to Report First Half, 2024 Results on Aug 27, 2024

Zhongzhu Healthcare Holding Co.,Ltd (SHSE:600568) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

First quarter 2024 earnings released: CN¥0.011 loss per share (vs CN¥0.014 loss in 1Q 2023)

Full year 2023 earnings released: CN¥0.17 loss per share (vs CN¥0.40 loss in FY 2022)

Zhongzhu Healthcare Holding Co.,Ltd, Annual General Meeting, May 08, 2024

Zhongzhu Healthcare Holding Co.,Ltd to Report Q1, 2024 Results on Apr 30, 2024

Zhongzhu Healthcare Holding Co.,Ltd to Report Fiscal Year 2023 Results on Apr 17, 2024

Third quarter 2023 earnings released: CN¥0.008 loss per share (vs CN¥0.009 loss in 3Q 2022)

Insufficient new directors

Second quarter 2023 earnings released: CN¥0.11 loss per share (vs CN¥0.011 loss in 2Q 2022)

Full year 2022 earnings released: CN¥0.40 loss per share (vs CN¥0.11 loss in FY 2021)

Third quarter 2022 earnings released: CN¥0.009 loss per share (vs CN¥0.008 loss in 3Q 2021)

Second quarter 2022 earnings released: CN¥0.011 loss per share (vs CN¥0.012 loss in 2Q 2021)

First quarter 2022 earnings released: CN¥0.002 loss per share (vs CN¥0.012 loss in 1Q 2021)

Full year 2021 earnings released: CN¥0.11 loss per share (vs CN¥0.002 profit in FY 2020)

Third quarter 2021 earnings released: CN¥0.008 loss per share (vs CN¥0.005 loss in 3Q 2020)

Second quarter 2021 earnings released: CN¥0.012 loss per share (vs CN¥0.003 loss in 2Q 2020)

Jilin Zhongke Bio-engineering Joint Stock Co., Ltd. signed the share transfer agreement to acquire a 51% stake in Zhongzhu Zhongke Stem Cell Gene Technology Co., Ltd. from Zhongzhu Healthcare Holding Co.,Ltd (SHSE:600568) for CNY 3 million.

Zeng Yamei won the bid and acquired 2.9% stake in Zhongzhu Healthcare Holding Co.,Ltd (SHSE:600568) from Zhuhai Zhongzhu Group Co., Ltd. for CNY 104.2 million.

Full year 2020 earnings released: EPS CN¥0.002 (vs CN¥0.18 loss in FY 2019)

Zhongzhu Healthcare's Shareholders to Sell 5.14% Stakes in the Company

New 90-day low: CN¥1.53

An unknown technology firm acquired 6.4% stake in Zhongzhu Healthcare Holding Co.,Ltd (SHSE:600568).

Xiao Feiying completed the acquisition of 6.26% stake in Zhongzhu Healthcare Holding Co.,Ltd (SHSE:600568) from the group of sellers.

Third quarter earnings released

Zhuhai Zhongzhu Co Ltd. agreed to be acquire the remaining 70.03% stake in Hubei Qianjiang Pharmaceutical Co., Ltd. (SHSE: 600568) in a reverse merger transaction .

First half earnings released

New 90-day high - CN¥1.50

Zhongzhu Healthcare Holding Co.,Ltd to Report First Half, 2020 Results on Aug 29, 2020

CEO（最高経営責任者

在職期間

取締役

平均在職期間

平均年齢

マネジメント基準チェック /14